| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.12 | 0.009 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | 0.16 | 0.01 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.01 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.071 | 0.02 |